Benjamin Lyons
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Psychiatry and Mental health top 5%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
Papers in ⓘ
-
- Bipolar Disorder and Treatment 2
- Electroconvulsive Therapy Studies 2
- Schizophrenia research and treatment 2
- Dementia and Cognitive Impairment Research 2
- Attention Deficit Hyperactivity Disorder 1
- Oncology 4
- HER2/EGFR in Cancer Research 3
- Peptidase Inhibition and Analysis 3
- Co-authors
- Eduard Vieta (2 shared papers)Michelle Kramer (1 shared paper)Sumant Khanna (1 shared paper)Mariëlle Eerdekens (1 shared paper)Fred Grossman (1 shared paper)Kimmie Ng (2 shared papers)Nathan Winslow (1 shared paper)Ina Rhee (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of the American Academy of Dermatology (1 paper)Clinical Cancer Research (1 paper)European Neuropsychopharmacology (1 paper)Dementia and Geriatric Cognitive Disorders (1 paper)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Benjamin Lyons
9 papers receiving 845 citations
Peers
Comparison fields: 5 of 81
- Oncology 468
- Psychiatry and Mental health 199
- Reproductive Medicine 86
- Radiology, Nuclear Medicine and Imaging 209
- Pulmonary and Respiratory Medicine 182
Countries citing papers authored by Benjamin Lyons
This map shows the geographic impact of Benjamin Lyons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Lyons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Lyons more than expected).
Fields of papers citing papers by Benjamin Lyons
This network shows the impact of papers produced by Benjamin Lyons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Lyons. The network helps show where Benjamin Lyons may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Lyons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 242 | |
| 2 | 2006 | 187 | |
| 3 | 2005 | 131 | |
| 4 | 2007 | 79 | |
| 5 | 2007 | 75 | |
| 6 | 2005 | 72 | |
| 7 | 2015 | 56 | |
| 8 | 2006 | 14 | |
| 9 | 2003 | 12 |
About Benjamin Lyons
Benjamin Lyons is a scholar working on Psychiatry and Mental health, Oncology, Dermatology, Water Science and Technology and Rheumatology, having authored 9 papers that have together received 868 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Peptidase Inhibition and Analysis (3 papers), Bipolar Disorder and Treatment (2 papers), Electroconvulsive Therapy Studies (2 papers), Schizophrenia research and treatment (2 papers), Dementia and Cognitive Impairment Research (2 papers), Cancer and Skin Lesions (1 paper) and Attention Deficit Hyperactivity Disorder (1 paper). The work is most often cited by research in Oncology (468 citations), Psychiatry and Mental health (199 citations), Reproductive Medicine (86 citations), Radiology, Nuclear Medicine and Imaging (209 citations) and Pulmonary and Respiratory Medicine (182 citations). Benjamin Lyons has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Eduard Vieta, Michelle Kramer, Sumant Khanna, Mariëlle Eerdekens, Fred Grossman, Kimmie Ng, Nathan Winslow, Ina Rhee, David C. Smith and Marcus Ballinger. Their work appears in journals such as Journal of Clinical Oncology, Journal of the American Academy of Dermatology, Clinical Cancer Research, European Neuropsychopharmacology and Dementia and Geriatric Cognitive Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.